A global study found COVID-19 booster vaccination during pregnancy was associated with lower odds of preeclampsia, even among ...

In this week’s edition of InnovationRx, we look at Jennifer Doudna’s $1 billion plan to bring Crispr gene editing to the real ...

Flashpoint Therapeutics, a biotechnology company pioneering a new class of structural nanomedicines, today announced a major, peer-reviewed publication demonstrating the power of ...

Seek Labs, a private TechBio company building a programmable disease response platform to detect, protect, and counter disease threats, has been awarded $2 million from the U.S. Department of ...

New research shows how poultry vaccination programs successfully combat Salmonella, with surprising insights into infection sources and prevention.

Researchers have reported that a topical gene therapy which can correct disease-causing mutations directly in human skin, raising the prospect of durable treatments for rare genetic skin ...

The idea of self-amplifying gene editing is to get cells to pass on packages of CRISPR machinery to their neighbours, boosting the effect ...

Nipah virus fatality rates are 40% to 75%. It's typically spread between humans and bats through people consuming ...

Among an upended global health order, medical innovation pushes forward. Read how TIME chose the list of doctors, scientists and more.

The American Medical Association (AMA) on Tuesday announced the launch of its own “evidence-based review process” of vaccine safety and efficacy for the next respiratory viral season, an apparent ...

The U.S.’s largest organization of physicians is joining forces with a vaccine research group to independently review vaccine science, effectively paralleling one of the Centers for Disease Control ...

Personalized Gene Editing Saves Baby in Record Time In early 2025, researchers successfully treated a baby boy with a rare, life-threatening disease by giving him a version of the CRISPR gene editor ...